David A. Siegel Haemonetics Corp Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Haemonetics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 62,555 shares of HAE stock, worth $5.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

62,555

Previous 130,355 52.01%

Holding current value

$5.18 Million

Previous $11.1 Million 52.1%

% of portfolio

0.01%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $4.83 Million - $5.79 Million	-67,800 Reduced 52.01%	62,555 $5.34 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $7.29 Million - $8.37 Million	-90,400 Reduced 40.95%	130,355 $11.1 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $2.46 Million - $2.79 Million	-29,800 Reduced 11.89%	220,755 $19.8 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $2.54 Million - $2.81 Million	-31,400 Reduced 11.14%	250,555 $21.3 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $1.78 Million - $2.22 Million	-24,500 Reduced 7.99%	281,955 $23.3 Million

Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $2.95 Million - $3.45 Million	-40,000 Reduced 11.55%	306,455 $24.1 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $4.11 Million - $5.11 Million	-64,900 Reduced 15.78%	346,455 $25.6 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $206,934 - $277,536	-4,200 Reduced 1.01%	411,355 $26.8 Million
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $5.04 Million - $7.28 Million	115,100 Added 38.31%	415,555 $26.3 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $193,245 - $290,901	3,900 Added 1.32%	300,455 $15.9 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $11.1 Million - $13.6 Million	192,600 Added 185.27%	296,555 $20.9 Million
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $3.34 Million - $7.65 Million	-64,500 Reduced 38.29%	103,955 $6.93 Million
Q1 2021 May 17, 2021	SELL	$111.01 - $139.48 $11.2 Million - $14.1 Million	-101,300 Reduced 37.55%	168,455 $18.7 Million
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $21 Million - $28.4 Million	-236,700 Reduced 46.74%	269,755 $32 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $16.8 Million - $20.8 Million	222,100 Added 78.11%	506,455 $44.2 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $8.14 Million - $11.4 Million	95,800 Added 50.81%	284,355 $25.5 Million
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $713,664 - $1.17 Million	9,600 Added 5.36%	188,555 $18.8 Million
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $4.51 Million - $5.1 Million	39,400 Added 28.23%	178,955 $20.6 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $790,244 - $934,317	-6,745 Reduced 4.61%	139,555 $17.6 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $2.31 Million - $3.4 Million	-28,255 Reduced 16.19%	146,300 $17.6 Million
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $1.74 Million - $2.13 Million	20,855 Added 13.57%	174,555 $15.3 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $743,865 - $956,949	-8,205 Reduced 5.07%	153,700 $15.4 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $3.08 Million - $3.92 Million	-34,255 Reduced 17.46%	161,905 $18.6 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $3.01 Million - $4.03 Million	42,060 Added 27.29%	196,160 $17.6 Million
Q1 2018 May 15, 2018	SELL	$60.72 - $74.41 $9.67 Million - $11.8 Million	-159,205 Reduced 50.81%	154,100 $11.3 Million
Q4 2017 Feb 14, 2018	BUY	$44.96 - $58.99 $9.86 Million - $12.9 Million	219,300 Added 233.29%	313,305 $18.2 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $3.8 Million - $4.22 Million	94,005	94,005 $4.22 Million

Others Institutions Holding HAE

# of Institutions

310

Shares Held

50.1M

Call Options Held

161K

Put Options Held

56.3K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.25B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account